{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADMET", "COVID-19", "DFT", "molecular docking", "papain-like protease", "pharmacophore", "semi-synthesized", "toxicity"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34771004", "DateCompleted": {"Year": "2021", "Month": "11", "Day": "19"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "10", "Day": "30"}], "Language": ["eng"], "ELocationID": ["6593", "10.3390/molecules26216593"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "21", "PubDate": {"Year": "2021", "Month": "Oct", "Day": "30"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "<i>In Silico</i> Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies.", "Abstract": {"AbstractText": ["Papain-like protease is an essential enzyme in the proteolytic processing required for the replication of SARS-CoV-2. Accordingly, such an enzyme is an important target for the development of anti-SARS-CoV-2 agents which may reduce the mortality associated with outbreaks of SARS-CoV-2. A set of 69 semi-synthesized molecules that exhibited the structural features of SARS-CoV-2 papain-like protease inhibitors (PLPI) were docked against the coronavirus papain-like protease (PLpro) enzyme (PDB ID: (4OW0). Docking studies showed that derivatives <b>34</b> and <b>58</b> were better than the co-crystallized ligand while derivatives <b>17</b>, <b>28</b>, <b>31</b>, <b>40</b>, <b>41</b>, <b>43</b>, <b>47</b>, <b>54</b>, and <b>65</b> exhibited good binding modes and binding free energies. The pharmacokinetic profiling study was conducted according to the four principles of the Lipinski rules and excluded derivative 31. Furthermore, ADMET and toxicity studies showed that derivatives <b>28</b>, <b>34</b>, and <b>47</b> have the potential to be drugs and have been demonstrated as safe when assessed via seven toxicity models. Finally, comparing the molecular orbital energies and the molecular electrostatic potential maps of <b>28</b>, <b>34</b>, and <b>47</b> against the co-crystallized ligand in a DFT study indicated that <b>28</b> is the most promising candidate to interact with the target receptor (PLpro)."]}, "AuthorList": [{"Identifier": ["0000-0001-9202-1754"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry and Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Alesawy", "ForeName": "Mohamed S", "Initials": "MS"}, {"Identifier": ["0000-0002-2546-8035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Almaarefa University, Ad Diriyah, Riyadh 13713, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": ["0000-0003-4497-5013"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia."}], "LastName": "Alsfouk", "ForeName": "Aisha A", "Initials": "AA"}, {"Identifier": ["0000-0001-8566-1980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}, {"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria 21934, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry and Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}], "GrantList": [{"GrantID": "Fast-track Research Funding program", "Agency": "the Deanship of Scientific Research at Princess Nourah bint Abdulrahman University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Peptide Hydrolases"}, {"RegistryNumber": "EC 3.4.22.2", "NameOfSubstance": "Coronavirus Papain-Like Proteases"}, {"RegistryNumber": "EC 3.4.22.2", "NameOfSubstance": "Papain"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Coronavirus Papain-Like Proteases"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Papain"}, {"QualifierName": ["metabolism"], "DescriptorName": "Peptide Hydrolases"}, {"QualifierName": ["chemistry", "metabolism", "pharmacology"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": ["drug effects", "metabolism", "pathogenicity"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Replication"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "WHO  WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 10 September 2021)].  Available online:  https://covid19.who.int/"}, {"Citation": "Ekins S., Mestres J., Testa B. In silico pharmacology for drug discovery: Applications to targets and beyond. Br. J. Pharmacol. 2007;152:21\u201337. doi: 10.1038/sj.bjp.0707306.", "ArticleIdList": ["10.1038/sj.bjp.0707306", "PMC1978280", "17549046"]}, {"Citation": "Marrone T.J., Briggs A., James M., McCammon J.A. Structure-based drug design: Computational advances. Annu. Rev. Pharmacol. Toxicol. 1997;37:71\u201390. doi: 10.1146/annurev.pharmtox.37.1.71.", "ArticleIdList": ["10.1146/annurev.pharmtox.37.1.71", "9131247"]}, {"Citation": "Li N., Wang Y., Li W., Li H., Yang L., Wang J., Mahdy H.A., Mehany A., Jaiash D.A., Santali E.Y. Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer\u2019s Agents Targeting BACE1 and PPAR\u03b3. J. Chem. 2020;2020:1631243. doi: 10.1155/2020/1631243.", "ArticleIdList": ["10.1155/2020/1631243"]}, {"Citation": "Abdel-Aziz H.A., Eldehna W.M., Fares M., Al-Rashood S.T., Al-Rashood K.A., Abdel-Aziz M.M., Soliman D.H. Synthesis, biological evaluation and 2D-QSAR study of halophenyl bis-hydrazones as antimicrobial and antitubercular agents. Int. J. Mol. Sci. 2015;16:8719\u20138743. doi: 10.3390/ijms16048719.", "ArticleIdList": ["10.3390/ijms16048719", "PMC4425105", "25903147"]}, {"Citation": "Yadav D.K., Khan F., Negi A.S. Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity. J. Mol. Model. 2012;18:2513\u20132525. doi: 10.1007/s00894-011-1265-3.", "ArticleIdList": ["10.1007/s00894-011-1265-3", "22038459"]}, {"Citation": "Zhang W., Pei J., Lai L. Computational multitarget drug design. J. Chem. Inf. Model. 2017;57:403\u2013412. doi: 10.1021/acs.jcim.6b00491.", "ArticleIdList": ["10.1021/acs.jcim.6b00491", "28166637"]}, {"Citation": "Youssef M.I., Zhou Y., Eissa I.H., Wang Y., Zhang J., Jiang L., Hu W., Qi J., Chen Z. Tetradecyl 2, 3-dihydroxybenzoate alleviates oligodendrocyte damage following chronic cerebral hypoperfusion through IGF-1 receptor. Neurochem. Int. 2020;138:104749. doi: 10.1016/j.neuint.2020.104749.", "ArticleIdList": ["10.1016/j.neuint.2020.104749", "32387468"]}, {"Citation": "Hadni H., Elhallaoui M. 2D and 3D-QSAR, molecular docking and ADMET properties in silico studies of azaaurones as antimalarial agents. New J. Chem. 2020;44:6553\u20136565. doi: 10.1039/C9NJ05767F.", "ArticleIdList": ["10.1039/C9NJ05767F"]}, {"Citation": "El-Metwally S.A., Abou-El-Regal M.M., Eissa I.H., Mehany A.B., Mahdy H.A., Elkady H., Elwan A., Elkaeed E.B. Discovery of thieno [2, 3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents. Bioorg. Chem. 2021;112:104947. doi: 10.1016/j.bioorg.2021.104947.", "ArticleIdList": ["10.1016/j.bioorg.2021.104947", "33964580"]}, {"Citation": "Alanazi M.M., Eissa I.H., Alsaif N.A., Obaidullah A.J., Alanazi W.A., Alasmari A.F., Albassam H., Elkady H., Elwan A. Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers. J. Enzym. Inhib. Med. Chem. 2021;36:1760\u20131782. doi: 10.1080/14756366.2021.1956488.", "ArticleIdList": ["10.1080/14756366.2021.1956488", "PMC8344243", "34340610"]}, {"Citation": "Alanazi M.M., Alaa E., Alsaif N.A., Obaidullah A.J., Alkahtani H.M., Al-Mehizia A.A., Alsubaie S.M., Taghour M.S., Eissa I.H. Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: Design, synthesis, and in silico studies. J. Enzym. Inhib. Med. Chem. 2021;36:1732\u20131750. doi: 10.1080/14756366.2021.1945591.", "ArticleIdList": ["10.1080/14756366.2021.1945591", "PMC8330740", "34325596"]}, {"Citation": "Alsaif N.A., Taghour M.S., Alanazi M.M., Obaidullah A.J., Al-Mehizia A.A., Alanazi M.M., Aldawas S., Elwan A., Elkady H. Discovery of new VEGFR-2 inhibitors based on bis ([1, 2, 4] triazolo)[4, 3-a: 3\u2019, 4\u2019-c] quinoxaline derivatives as anticancer agents and apoptosis inducers. J. Enzym. Inhib. Med. Chem. 2021;36:1093\u20131114. doi: 10.1080/14756366.2021.1915303.", "ArticleIdList": ["10.1080/14756366.2021.1915303", "PMC8168755", "34056992"]}, {"Citation": "Alsaif N.A., Dahab M.A., Alanazi M.M., Obaidullah A.J., Al-Mehizia A.A., Alanazi M.M., Aldawas S., Mahdy H.A., Elkady H. New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis. Bioorg. Chem. 2021;110:104807. doi: 10.1016/j.bioorg.2021.104807.", "ArticleIdList": ["10.1016/j.bioorg.2021.104807", "33721808"]}, {"Citation": "El-Adl K., Ibrahim M.-K., Alesawy M.S., Eissa I.H. [1, 2, 4] Triazolo [4, 3-c] quinazoline and bis ([1, 2, 4] triazolo)[4, 3-a: 4\u2032, 3\u2032-c] quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies. Bioorg. Med. Chem. 2021;30:115958. doi: 10.1016/j.bmc.2020.115958.", "ArticleIdList": ["10.1016/j.bmc.2020.115958", "33360576"]}, {"Citation": "Parmar D.R., Soni J.Y., Guduru R., Rayani R.H., Kusurkar R.V., Vala A.G., Talukdar S.N., Eissa I.H., Metwaly A.M., Khalil A. Discovery of new anticancer thiourea-azetidine hybrids: Design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Bioorg. Chem. 2021;115:105206. doi: 10.1016/j.bioorg.2021.105206.", "ArticleIdList": ["10.1016/j.bioorg.2021.105206", "34339975"]}, {"Citation": "Jalmakhanbetova R.I., Suleimen Y.M., Oyama M., Elkaeed E.B., Eissa I., Suleimen R.N., Metwaly A.M., Ishmuratova M.Y. Isolation and In Silico Anti-COVID-19 Main Protease (Mpro) Activities of Flavonoids and a Sesquiterpene Lactone from Artemisia sublessingiana. J. Chem. 2021;2021:5547013. doi: 10.1155/2021/5547013.", "ArticleIdList": ["10.1155/2021/5547013"]}, {"Citation": "Al-Karmalawy A.A., Dahab M.A., Metwaly A.M., Elhady S.S., Elkaeed E.B., Eissa I.H., Darwish K.M. Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor. Front. Chem. 2021;9:661230. doi: 10.3389/fchem.2021.661230.", "ArticleIdList": ["10.3389/fchem.2021.661230", "PMC8129187", "34017819"]}, {"Citation": "Alesawy M.S., Abdallah A.E., Taghour M.S., Elkaeed E.B., Eissa I.H., Metwaly A.M. In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) Molecules. 2021;26:2806. doi: 10.3390/molecules26092806.", "ArticleIdList": ["10.3390/molecules26092806", "PMC8126168", "34068579"]}, {"Citation": "El-Demerdash A., Metwaly A.M., Hassan A., El-Aziz A., Mohamed T., Elkaeed E.B., Eissa I.H., Arafa R.K., Stockand J.D. Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS-CoV-2 (COVID-19) Biomolecules. 2021;11:460. doi: 10.3390/biom11030460.", "ArticleIdList": ["10.3390/biom11030460", "PMC8003478", "33808721"]}, {"Citation": "Imieje V.O., Zaki A.A., Metwaly A.M., Mostafa A.E., Elkaeed E.B., Falodun A. Comprehensive In Silico Screening of the Antiviral Potentialities of a New Humulene Glucoside from Asteriscus hierochunticus against SARS-CoV-2. J. Chem. 2021;2021:5541876. doi: 10.1155/2021/5541876.", "ArticleIdList": ["10.1155/2021/5541876"]}, {"Citation": "Metwaly A.M., Ghoneim M.M., Eissa I.H., Elsehemy I.A., Mostafa A.E., Hegazy M.M., Afifi W.M., Dou D. Traditional ancient Egyptian medicine: A review. Saudi J. Biol. Sci. 2021;28:5823\u20135832. doi: 10.1016/j.sjbs.2021.06.044.", "ArticleIdList": ["10.1016/j.sjbs.2021.06.044", "PMC8459052", "34588897"]}, {"Citation": "Han X., Yang Y., Metwaly A.M., Xue Y., Shi Y., Dou D. The Chinese herbal formulae (Yitangkang) exerts an antidiabetic effect through the regulation of substance metabolism and energy metabolism in type 2 diabetic rats. J. Ethnopharmacol. 2019;239:111942. doi: 10.1016/j.jep.2019.111942.", "ArticleIdList": ["10.1016/j.jep.2019.111942", "31075380"]}, {"Citation": "Metwaly A.M., Lianlian Z., Luqi H., Deqiang D. Black ginseng and its saponins: Preparation, phytochemistry and pharmacological effects. Molecules. 2019;24:1856. doi: 10.3390/molecules24101856.", "ArticleIdList": ["10.3390/molecules24101856", "PMC6572638", "31091790"]}, {"Citation": "Wang Y.-M., Ran X.-K., Riaz M., Yu M., Cai Q., Dou D.-Q., Metwaly A.M., Kang T.-G., Cai D.-C. Chemical constituents of stems and leaves of Tagetespatula L. and its fingerprint. Molecules. 2019;24:3911. doi: 10.3390/molecules24213911.", "ArticleIdList": ["10.3390/molecules24213911", "PMC6864839", "31671631"]}, {"Citation": "Metwaly A. Comparative biological evaluation of four endophytic fungi isolated from nigella sativa seeds. Al-Azhar J. Pharm. Sci. 2019;59:123\u2013136. doi: 10.21608/ajps.2019.64111.", "ArticleIdList": ["10.21608/ajps.2019.64111"]}, {"Citation": "Metwaly A.M., Wanas A.S., Radwan M.M., Ross S.A., ElSohly M.A. New \u03b1-Pyrone derivatives from the endophytic fungus Embellisia sp. Med. Chem. Res. 2017;26:1796\u20131800. doi: 10.1007/s00044-017-1889-7.", "ArticleIdList": ["10.1007/s00044-017-1889-7"]}, {"Citation": "Metwaly A.M., Ghoneim M.M., Musa A. Two new antileishmanial diketopiperazine alkaloids from the endophytic fungus Trichosporum sp. Derpharmachemica. 2015;7:322\u2013327."}, {"Citation": "Ghoneim M.M., Afifi W.M., Ibrahim M., Elagawany M., Khayat M.T., Aboutaleb M.H., Metwaly A.M. Biological evaluation and molecular docking study of metabolites from Salvadora Persica L. Growing in Egypt. Pharmacogn. Mag. 2019;15:232."}, {"Citation": "Liu L., Luo S., Yu M., Metwaly A.M., Ran X., Ma C., Dou D., Cai D. Chemical Constituents of Tagetes patula and Their Neuroprotecting Action. Nat. Prod. Commun. 2020;15:1\u20138."}, {"Citation": "Yassin A.M., El-Deeb N.M., Metwaly A.M., El Fawal G.F., Radwan M.M., Hafez E.E. Induction of apoptosis in human cancer cells through extrinsic and intrinsic pathways by Balanites aegyptiaca furostanol saponins and saponin-coated silvernanoparticles. Appl. Biochem. Biotechnol. 2017;182:1675\u20131693. doi: 10.1007/s12010-017-2426-3.", "ArticleIdList": ["10.1007/s12010-017-2426-3", "28236195"]}, {"Citation": "Sharaf M.H., El-Sherbiny G.M., Moghannem S.A., Abdelmonem M., Elsehemy I.A., Metwaly A.M., Kalaba M.H. New combination approaches to combat methicillin-resistant Staphylococcus aureus (MRSA) Sci. Rep. 2021;11:1\u201316. doi: 10.1038/s41598-021-82550-4.", "ArticleIdList": ["10.1038/s41598-021-82550-4", "PMC7896049", "33608582"]}, {"Citation": "Suleimen Y.M., Metwaly A.M., Mostafa A.E., Elkaeed E.B., Liu H.-W., Basnet B.B., Suleimen R.N., Ishmuratova M.Y., Turdybekov K.M., Van Hecke K. Isolation, Crystal Structure, and In Silico Aromatase Inhibition Activity of Ergosta-5, 22-dien-3\u03b2-ol from the Fungus Gyromitra esculenta. J. Chem. 2021;2021:5529786. doi: 10.1155/2021/5529786.", "ArticleIdList": ["10.1155/2021/5529786"]}, {"Citation": "Metwaly A.M., Kadry H.A., Atef A., Mohammad A.-E.I., Ma G., Cutler S.J., Ross S.A. Nigrosphaerin A a new isochromene derivative from the endophytic fungus Nigrospora sphaerica. Phytochem. Lett. 2014;7:1\u20135. doi: 10.1016/j.phytol.2013.09.001.", "ArticleIdList": ["10.1016/j.phytol.2013.09.001", "PMC5047436", "27708743"]}, {"Citation": "Metwaly A.M., Fronczek F.R., Ma G., Kadry H.A., Atef A., Mohammad A.-E.I., Cutler S.J., Ross S.A. Antileukemic \u03b1-pyrone derivatives from the endophytic fungus Alternaria phragmospora. Tetrahedron Lett. 2014;55:3478\u20133481. doi: 10.1016/j.tetlet.2014.04.085.", "ArticleIdList": ["10.1016/j.tetlet.2014.04.085", "PMC5047437", "27708462"]}, {"Citation": "Zhanzhaxina A., Suleimen Y., Metwaly A.M., Eissa I.H., Elkaeed E.B., Suleimen R., Ishmuratova M., Akatan K., Luyten W. In Vitro and In Silico Cytotoxic and Antibacterial Activities of a Diterpene from Cousinia alata Schrenk. J. Chem. 2021;2021:5542455. doi: 10.1155/2021/5542455.", "ArticleIdList": ["10.1155/2021/5542455"]}, {"Citation": "Imieje V.O., Zaki A.A., Metwaly A.M., Eissa I.H., Elkaeed E.B., Ali Z., Khan I.A., Falodun A. Antileishmanial Derivatives of Humulene from Asteriscus hierochunticus with in silico Tubulin Inhibition Potential. Rec. Nat. Prod. 2021;16:150\u2013171."}, {"Citation": "Jalmakhanbetova R., Elkaeed E.B., Eissa I.H., Metwaly A.M., Suleimen Y.M. Synthesis and Molecular Docking of Some Grossgemin Amino Derivatives as Tubulin Inhibitors Targeting Colchicine Binding Site. J. Chem. 2021;2021:5586515. doi: 10.1155/2021/5586515.", "ArticleIdList": ["10.1155/2021/5586515"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 2016;79:629\u2013661. doi: 10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "da Rosa R., Schenkel E.P., Bernardes L.S.C. Semisynthetic and newly designed derivatives based on natural chemical scaffolds: Moving beyond natural products to fight Trypanosoma cruzi. Phytochem. Rev. 2020;19:105\u2013122. doi: 10.1007/s11101-020-09659-8.", "ArticleIdList": ["10.1007/s11101-020-09659-8"]}, {"Citation": "S\u00e1nchez-Recillas A., Navarrete-V\u00e1zquez G., Hidalgo-Figueroa S., Rios M.Y., Ibarra-Barajas M., Estrada-Soto S. Semisynthesis, ex vivo evaluation, and SAR studies of coumarin derivatives as potential antiasthmatic drugs. Eur. J. Med. Chem. 2014;77:400\u2013408. doi: 10.1016/j.ejmech.2014.03.029.", "ArticleIdList": ["10.1016/j.ejmech.2014.03.029", "24681028"]}, {"Citation": "Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A., Schulz L., Widera M., Mehdipour A.R., Tascher G., et al. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature. 2020;587:657\u2013662. doi: 10.1038/s41586-020-2601-5.", "ArticleIdList": ["10.1038/s41586-020-2601-5", "PMC7116779", "32726803"]}, {"Citation": "B\u00e1ez-Santos Y.M., John S.E.S., Mesecar A.D. The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds. Antivir. Res. 2015;115:21\u201338. doi: 10.1016/j.antiviral.2014.12.015.", "ArticleIdList": ["10.1016/j.antiviral.2014.12.015", "PMC5896749", "25554382"]}, {"Citation": "Ratia K., Pegan S., Takayama J., Sleeman K., Coughlin M., Baliji S., Chaudhuri R., Fu W., Prabhakar B.S., Johnson M.E. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc. Natl. Acad. Sci. USA. 2008;105:16119\u201316124. doi: 10.1073/pnas.0805240105.", "ArticleIdList": ["10.1073/pnas.0805240105", "PMC2571001", "18852458"]}, {"Citation": "B\u00e1ez-Santos Y.M., Barraza S.J., Wilson M.W., Agius M.P., Mielech A.M., Davis N.M., Baker S.C., Larsen S.D., Mesecar A.D. X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases. J. Med. Chem. 2014;57:2393\u20132412. doi: 10.1021/jm401712t.", "ArticleIdList": ["10.1021/jm401712t", "PMC3983375", "24568342"]}, {"Citation": "Osipiuk J., Azizi S.-A., Dvorkin S., Endres M., Jedrzejczak R., Jones K.A., Kang S., Kathayat R.S., Kim Y., Lisnyak V.G. Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors. Nat. Commun. 2021;12:1\u20139. doi: 10.1038/s41467-021-21060-3.", "ArticleIdList": ["10.1038/s41467-021-21060-3", "PMC7854729", "33531496"]}, {"Citation": "Abdallah A.E., Alesawy M.S., Eissa S.I., El-Fakharany E.M., Kalaba M.H., Sharaf M.H., Shama N.M.A., Mahmoud S.H., Mostafa A., Al-Karmalawy A.A., et al. Design and synthesis of new 4-(2-nitrophenoxy) benzamide derivatives as potential antiviral agents: Molecular modeling and in vitro antiviral screening. New J. Chem. 2021;45:16557\u201316571. doi: 10.1039/D1NJ02710G.", "ArticleIdList": ["10.1039/D1NJ02710G"]}, {"Citation": "Rut W., Lv Z., Zmudzinski M., Patchett S., Nayak D., Snipas S.J., Oualid F.E., Huang T.T., Bekes M., Drag M., et al. Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti\u2013COVID-19 drug design. Sci. Adv. 2020;6:eabd4596. doi: 10.1126/sciadv.abd4596.", "ArticleIdList": ["10.1126/sciadv.abd4596", "PMC7567588", "33067239"]}, {"Citation": "Laboratory E. Natural-Product-Based Library.  [(accessed on 11 August 2021)].  Available online:  https://eximedlab.com/Screening-Compounds.html."}, {"Citation": "Veber D.F., Johnson S.R., Cheng H.-Y., Smith B.R., Ward K.W., Kopple K.D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002;45:2615\u20132623. doi: 10.1021/jm020017n.", "ArticleIdList": ["10.1021/jm020017n", "12036371"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997;23:3\u201325. doi: 10.1016/S0169-409X(96)00423-1.", "ArticleIdList": ["10.1016/S0169-409X(96)00423-1", "11259830"]}, {"Citation": "Xia X., Maliski E.G., Gallant P., Rogers D. Classification of kinase inhibitors using a Bayesian model. J. Med. Chem. 2004;47:4463\u20134470. doi: 10.1021/jm0303195.", "ArticleIdList": ["10.1021/jm0303195", "15317458"]}, {"Citation": "BIOVIA. QSAR, ADMET and Predictive Toxicology.  [(accessed on 11 September 2021)].  Available online:  https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/qsar-admet-and-predictive-toxicology.html."}, {"Citation": "Venkatapathy R., Wang N.C.Y., Martin T.M., Harten P.F., Young D. Structure\u2013Activity Relationships for Carcinogenic Potential. Gen. Appl. Syst. Toxicol. 2009 doi: 10.1002/9780470744307.gat079.", "ArticleIdList": ["10.1002/9780470744307.gat079"]}, {"Citation": "Goodrnan G., Wilson R. Comparison of the dependence of the TD50 on maximum tolerated dose for mutagens and nonmutagens. Risk Anal. 1992;12:525\u2013533. doi: 10.1111/j.1539-6924.1992.tb00709.x.", "ArticleIdList": ["10.1111/j.1539-6924.1992.tb00709.x", "1480798"]}, {"Citation": "Council N.R. Issues in Risk Assessment. National Academies Press (US); Washington, DC, USA: 1993. Correlation between carcinogenic potency and the maximum tolerated dose: Implications for risk assessment.", "ArticleIdList": ["8234946"]}, {"Citation": "Gonella Diaza R., Manganelli S., Esposito A., Roncaglioni A., Manganaro A., Benfenati E. Comparison of in silico tools for evaluating rat oral acute toxicity. SAR QSAR Environ. Res. 2015;26:1\u201327. doi: 10.1080/1062936X.2014.977819.", "ArticleIdList": ["10.1080/1062936X.2014.977819", "25567032"]}, {"Citation": "Pizzo F., Benfenati E. In Silico Methods for Predicting Drug Toxicity. Springer; Berlin/Heidelberg, Germany: 2016. In silico models for repeated-dose toxicity (RDT): Prediction of the no observed adverse effect level (NOAEL) and lowest observed adverse effect level (LOAEL) for drugs; pp. 163\u2013176.", "ArticleIdList": ["27311467"]}, {"Citation": "Venkatapathy R., Moudgal C.J., Bruce R.M. Assessment of the oral rat chronic lowest observed adverse effect level model in TOPKAT, a QSAR software package for toxicity prediction. J. Chem. Inf. Comput. Sci. 2004;44:1623\u20131629. doi: 10.1021/ci049903s.", "ArticleIdList": ["10.1021/ci049903s", "15446819"]}, {"Citation": "Wilhelmus K.R. The Draize eye test. Surv. Ophthalmol. 2001;45:493\u2013515. doi: 10.1016/S0039-6257(01)00211-9.", "ArticleIdList": ["10.1016/S0039-6257(01)00211-9", "11425356"]}, {"Citation": "Bosshard E. Review on skin and mucous-membrane irritation tests and their application. Food Chem. Tox. 1985;23:149\u2013154. doi: 10.1016/0278-6915(85)90007-9.", "ArticleIdList": ["10.1016/0278-6915(85)90007-9", "3891553"]}, {"Citation": "Subashchandrabose S., Saleem H., Erdogdu Y., Rajarajan G., Thanikachalam V. FT-Raman, FT-IR spectra and total energy distribution of 3-pentyl-2, 6-diphenylpiperidin-4-one: DFT method. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2011;82:260\u2013269. doi: 10.1016/j.saa.2011.07.046.", "ArticleIdList": ["10.1016/j.saa.2011.07.046", "21862393"]}, {"Citation": "Huerta-Aguilar C.A., Palos-Barba V., Thangarasu P., Koodali R.T. Visible light driven photo-degradation of Congo red by TiO2ZnO/Ag: DFT approach on synergetic effect on band gap energy. Chemosphere. 2018;213:481\u2013497. doi: 10.1016/j.chemosphere.2018.09.053.", "ArticleIdList": ["10.1016/j.chemosphere.2018.09.053", "30245225"]}, {"Citation": "Mohammed H.S., Tripathi V.D., Darghouth A.A. Journal of Physics: Conference Series. IOP Publishing; Bristol, UK: 2019. Synthesis, Characterization, DFT calculation and Antimicrobial Activity of Co (II) and Cu (II) complexes with azo dye; p. 052051."}, {"Citation": "Fleming I. Frontier Orbitals and Organic Chemical Reactions. Wiley; Hoboken, NJ, USA: 1977."}, {"Citation": "El-Nahass M., Kamel M., El-Deeb A., Atta A., Huthaily S. Ab initio HF, DFT and experimental (FT-IR) investigation of vibrational spectroscopy of PN, N-dimethylaminobenzylidenemalononitrile (DBM) Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2011;79:443\u2013450. doi: 10.1016/j.saa.2011.02.055.", "ArticleIdList": ["10.1016/j.saa.2011.02.055", "21514212"]}, {"Citation": "Aihara J.-I. Correlation found between the HOMO\u2013LUMO energy separation and the chemical reactivity at the most reactive site for isolated-pentagon isomers of fullerenes. Phys. Chem. Chem. Phys. 2000;2:3121\u20133125. doi: 10.1039/b002601h.", "ArticleIdList": ["10.1039/b002601h"]}, {"Citation": "Suhasini M., Sailatha E., Gunasekaran S., Ramkumaar G. Vibrational and electronic investigations, thermodynamic parameters, HOMO and LUMO analysis on Lornoxicam by density functional theory. J. Mol. Struct. 2015;1100:116\u2013128. doi: 10.1016/j.molstruc.2015.07.003.", "ArticleIdList": ["10.1016/j.molstruc.2015.07.003"]}, {"Citation": "Bitencourt-Ferreira G., de Azevedo Junior W.F. Electrostatic Potential Energy in Protein-Drug Complexes. Curr. Med. Chem. 2021;28:4954\u20134971. doi: 10.2174/0929867328666210201150842.", "ArticleIdList": ["10.2174/0929867328666210201150842", "33593246"]}, {"Citation": "Matin M.M., Hasan M.S., Uzzaman M., Bhuiyan M.M.H., Kibria S.M., Hossain M.E., Roshid M.H. Synthesis, spectroscopic characterization, molecular docking, and ADMET studies of mannopyranoside esters as antimicrobial agents. J. Mol. Struct. 2020;1222:128821. doi: 10.1016/j.molstruc.2020.128821.", "ArticleIdList": ["10.1016/j.molstruc.2020.128821"]}, {"Citation": "X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases. 2021.  [(accessed on 11 September 2021)].  Available online:  https://www.rcsb.org/structure/4OW0.", "ArticleIdList": ["PMC3983375", "24568342"]}, {"Citation": "El-Gamal K.M., El-Morsy A.M., Saad A.M., Eissa I.H., Alswah M. Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors. J. Mol. Struct. 2018;1166:15\u201333. doi: 10.1016/j.molstruc.2018.04.010.", "ArticleIdList": ["10.1016/j.molstruc.2018.04.010"]}, {"Citation": "Yousef R., Sakr H., Eissa I., Mehany A., Metwaly A., Elhendawy M.A., Radwan M., ElSohly M.A., Abulkhair H.S., El-Adl K. New quinoxaline-2 (1H)-ones as potential VEGFR-2 inhibitors: Design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations. New J. Chem. 2021;45:16949\u201316964. doi: 10.1039/D1NJ02509K.", "ArticleIdList": ["10.1039/D1NJ02509K", "34175720"]}, {"Citation": "Amer H.H., Alotaibi S.H., Trawneh A.H., Metwaly A.M., Eissa I.H. Anticancer activity, spectroscopic and molecular docking of some new synthesized sugar hydrazones, Arylidene and \u03b1-Aminophosphonate derivatives. Arab. J. Chem. 2021;14:103348. doi: 10.1016/j.arabjc.2021.103348.", "ArticleIdList": ["10.1016/j.arabjc.2021.103348"]}, {"Citation": "Alesawy M.S., Al-Karmalawy A.A., Elkaeed E.B., Alswah M., Belal A., Taghour M.S., Eissa I.H. Design and discovery of new 1, 2, 4-triazolo [4, 3-c] quinazolines as potential DNA intercalators and topoisomerase II inhibitors. Arch. Der Pharm. 2021;354:2000237. doi: 10.1002/ardp.202000237.", "ArticleIdList": ["10.1002/ardp.202000237", "33226150"]}, {"Citation": "Eissa I.H., Khalifa M.M., Elkaeed E.B., Hafez E.E., Alsfouk A.A., Metwaly A.M. In Silico Exploration of Potential Natural Inhibitors against SARS-CoV-2 nsp10. Molecules. 2021;26:6151. doi: 10.3390/molecules26206151.", "ArticleIdList": ["10.3390/molecules26206151", "PMC8539059", "34684735"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "9", "Day": "13"}, {"Year": "2021", "Month": "10", "Day": "26"}, {"Year": "2021", "Month": "10", "Day": "28"}, {"Year": "2021", "Month": "11", "Day": "13", "Hour": "1", "Minute": "13"}, {"Year": "2021", "Month": "11", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["34771004", "PMC8588135", "10.3390/molecules26216593", "molecules26216593"]}}], "PubmedBookArticle": []}